| __timestamp | Bausch Health Companies Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 4167274 |
| Thursday, January 1, 2015 | 2645000000 | 5247851 |
| Friday, January 1, 2016 | 2611000000 | 4925118 |
| Sunday, January 1, 2017 | 2548000000 | 14930297 |
| Monday, January 1, 2018 | 2351000000 | 25371768 |
| Tuesday, January 1, 2019 | 2350000000 | 23921274 |
| Wednesday, January 1, 2020 | 2249000000 | 25338236 |
| Friday, January 1, 2021 | 2394000000 | 20182966 |
| Saturday, January 1, 2022 | 2364000000 | 17562000 |
| Sunday, January 1, 2023 | 2559000000 | 25212000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. This analysis compares the cost of revenue trends for Pharming Group N.V. and Bausch Health Companies Inc. from 2014 to 2023. Over this period, Bausch Health consistently reported higher costs, peaking in 2015 with a 17% increase from the previous year. In contrast, Pharming Group N.V. experienced a significant rise in 2017, with costs surging by over 200% compared to 2016. This divergence highlights the varying operational scales and strategies of these companies. While Bausch Health's costs remained relatively stable, Pharming's fluctuations suggest strategic shifts or market responses. As the industry faces challenges like regulatory changes and market competition, these insights offer a glimpse into how major players manage their financial strategies.
Analyzing Cost of Revenue: AbbVie Inc. and Bausch Health Companies Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Pharming Group N.V.
Cost Insights: Breaking Down Incyte Corporation and Pharming Group N.V.'s Expenses
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs PTC Therapeutics, Inc.
Cost of Revenue Trends: Pharming Group N.V. vs HUTCHMED (China) Limited
Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Galapagos NV's Expenses
Cost of Revenue Trends: Pharming Group N.V. vs Evotec SE
Analyzing Cost of Revenue: Perrigo Company plc and Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Bausch Health Companies Inc. vs Evotec SE